Why is "Dopamine agonist" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-09 13:53:07
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
A dopamine agonist is a compound that activates dopamine D2 receptors and belong to one of two different subclasses: ergoline and non-ergoline. Examples of ergoline agonists are cabergoline and bromocriptine and examples of non-ergoline agonists are pramipexole, ropinirole and rotigotine. Ergoline agonists have been linked to cartilage formation in heart valves.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Tavapadon as a Novel Partial D1/D5 Selective Dopamine Agonist in Parkinson's Disease - NeurologyLive
-
Drug warnings review after some patients 'misled' over impulsive behaviour side effects - BBC
-
Case Report: Near-fatal adverse effects of dopamine agonist for the treatment of restless legs syndrome - Frontiers
-
Study finds further links between impulse control disorder and dopamine agonist medication - Parkinson's Europe
-
Is it Time to Reshuffle the Medications? - Neurology Today
-
Ergot Alkaloids - Dopamine agonist market outlook - Grand View Research
-
Restless Leg Syndrome May Be Tied to Parkinson's Risk - MedPage Today
-
Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway - Yahoo Finance
-
Dopamine Agonist Market Grows to $1.83 Billion Amid Rising Parkinson’s Cases – Led by Pfizer, Novartis, and Teva Pharmaceuticals | The Research Insights - vocal.media
-
Case Report: Prolonged DAWS in an RLS patient under severe relational stress - Frontiers
-
Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome - NeurologyLive
-
A major change for restless legs treatment - Harvard Health
-
'My husband stole £600k for sex and antiques' - drug side effects tearing families apart - BBC
-
LEVODOPA VERSUS DOPAMINE AGONISTS - Neurology Today
-
Delayed Dopamine Agonist Withdrawal Syndrome After Deep Brain Stimulation for Parkinson Disease - Neurology® Journals
-
'It's ruined my life': Hundreds tell BBC how medication triggered gambling and other addictions - BBC
-
Weaning Patients With RLS Off Dopamine Agonists a Gradual Process - Neurology Today
-
Tavapadon Shows Promise for Early and Advanced Parkinson’s - Cleveland Clinic
-
The Dopamine Agonist Bromocriptine Differentially Affects Fronto-Striatal Functional Connectivity During Working Memory - Frontiers
-
Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia - Frontiers
-
Crack cocaine use due to dopamine agonist therapy in Parkinson disease - Neurology® Journals
-
Change in Insulin Sensitivity and Lipid Profile After Dopamine Agonist Therapy in Patients With Prolactinoma - Cureus
-
Dopamine Agonist Withdrawal Syndrome and Suicidality in Parkinson’s Disease - Cambridge University Press & Assessment
-
Risk of Diabetes Caused by Antipsychotics Decreased by Pancreas Specific Dopamine Agonist - Genetic Engineering and Biotechnology News
-
Delusional Infestation Secondary to the Dopamine Agonist Ropirinole in a Patient With Parkinson's Disease: A Case Report With an Outline of the Biology of Psychosis - Cureus
-
Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity - PLOS
-
Dopamine agonist monotherapy in Parkinson's disease - The Lancet
-
Cabergoline as a Preventive Migraine Treatment: An Investigator-Initiated Randomized Controlled Trial - medrxiv.org
-
Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease - Nature
-
EAN 2024: sublingual apomorphine for dopamine agonist users - Pharmaceutical Technology
-
Dopamine receptor agonists may be associated with impulse control disorders - 2 Minute Medicine
-
‘Dopamine Agonists Should Not Be a First-line Treatment for Restless Legs Syndrome’ - Sleep Review
-
Dopamine agonist: Drug wey fit make women develop dangerous sexual addiction wey doctors no warn about - BBC
-
Addressing Augmentation in Restless Leg Syndrome - NeurologyLive
-
Letter re: The terrorist inside my husband's brain - Neurology® Journals
-
'My dad started spying on my mum' - the drugs causing sexual urges - BBC
-
A reassessment of risks and benefits of dopamine agonists in Parkinson's disease - The Lancet
-
Managing Hypersexuality and Parkinson's Disease - Medscape
-
'Prescription medication made me a gambling addict' - BBC
-
Impulse Control Disorders and Dopamine-Related Creativity: Pathogenesis and Mechanism, Short Review, and Hypothesis - Frontiers
-
Impulse Control Disorders in Parkinson’s Disease | American Journal of Psychiatry - Psychiatry Online
-
Reducing Dosage of Parkinson's Drugs Can Cause Symptoms Similar to Those of Cocaine Withdrawal - WCM Newsroom
-
FDA approves ophthalmic emetic for dogs - DVM360
-
Don’t Light the Fuse of Restless Legs Syndrome with Dopamine Agonists - Sleep Review
-
Dopamine Agonists and Valvular Heart Disease - NEJM
-
Pregabalin improves symptoms of restless legs syndrome - 2 Minute Medicine
-
An RLS Prescription Revolution May Have Begun - Sleep Review
-
PD Patients Report Better Sleep With Rotigotine Tx - MedPage Today
-
AbbVie’s tavapadon holds potential to become prominent treatment in dopamine agonist market: GlobalData - Express Pharma
-
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation - NEJM
-
Warning: this Parkinson’s drug can make you addicted to gambling, sex, or food - vox.com
-
A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications - Wiley Online Library
-
Watchdog sues FDA for dragging its feet on Parkinson's drug warnings - Fierce Pharma
-
Doctors didn't warn women of 'risky sex' drug urges - BBC
-
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease - NEJM
-
Mapping the Effects of Three Dopamine Agonists with Different Dyskinetogenic Potential and Receptor Selectivity Using Pharmacological Functional Magnetic Resonance Imaging - Nature
-
Cutting Parkinson's Drug Dose Linked to Withdrawal Effects - ABC News - Breaking News, Latest News and Videos
-
Man Says Parkinson's Drug Made Him Addicted to Gambling and Gay Sex - ABC News - Breaking News, Latest News and Videos
-
Parkinson’s Drug Shows Promise | Newswise - Newswise
-
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa - NEJM
-
Parkinson's Patient Sues GlaxoSmithKline Over Requip's Behavioral Side Effects - thelegaljournal.com
-
Pfizer Agrees to Pay Off Parkinson Patients Who Developed Gambling and Sex Addiction While On Cabaser - BioSpace
-
Prescription for an obsession? - NBC News
-
'Deviant' women 'cruising street for sex' due to common drugs' side effect - The Sun
-
Health | Skin patch hope for Parkinson's - BBC
-
Health | Parkinson's drugs 'fuel gambling urge' - BBC
-
Patients to launch class action over Parkinson's drug - Australian Broadcasting Corporation
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.